Respiratory failure and extracorporeal membrane oxygenation

Area of Science:

• Cardiovascular and Respiratory System Physiology
• Medical Technology and Device Engineering

Background:

• Conventional treatment for respiratory failure relies on positive pressure ventilation and high oxygen concentrations.
• Extracorporeal membrane oxygenation (ECMO) serves as an alternative when conventional methods are insufficient for adequate gas exchange.

Purpose of the Study:

• To evaluate the efficacy and survival rates of ECMO in neonates and pediatric patients with respiratory insufficiency.
• To highlight ECMO as a potential treatment for reversible pulmonary diseases unresponsive to standard care.

Main Methods:

• ECMO involves withdrawing blood from a central vein, pumping it through an artificial oxygenator, and returning it to the patient (veno-arterial or veno-venous).
• This extracorporeal system facilitates total gas exchange, allowing lungs to rest from high-pressure ventilation.

Main Results:

• Over 21,500 neonates treated with ECMO show a 76% survival rate; Meconium aspiration syndrome has 94% survival, while congenital diaphragmatic hernia has 52%.
• 3,500 pediatric patients (30 days-18 years) treated with ECMO have a 56% survival rate, with aspiration and viral pneumonia having the highest survival.
• Randomized studies confirm ECMO's survival advantage in neonates; non-randomized pediatric studies indicate lower mortality with ECMO.

Conclusions:

• ECMO is a critical intervention for severe respiratory insufficiency in neonates and pediatric patients with reversible pulmonary conditions.
• ECMO significantly improves survival outcomes, particularly in neonates, and offers a viable alternative for pediatric cases unresponsive to conventional ventilation.